A PET/CT scan was performed with different radiopharmaceuticals according to clinical indication, respectively, 18F-FDG for LC and MM, 68Ga-DOTATOC for GEP NET and 68Ga-labeled prostate-specific membrane antigen (68Ga-PSMA) for PCA. This evidence concerns the gene FOLH1 and posterior cortical atrophy.